In response to President Joe Biden unveiling new vaccination mandates for employers with more than 100 employees, FMI and the Consumer Brand Association are responding.
Garcoa Labs’ Greg and Richie Rubin shared information and ideas with Kinzinger about how to bolster the “Made in America” movement and grow the country’s manufacturing jobs.
The efforts from pharmacy organizations follow the Food and Drug Administration recently authorizing the first post-exposure prophylaxis for COVID-19 emergency use.
Jeffrey K. France, vice president and general counsel at the Association for Accessible Medicines, discusses how two major decisions made by the Supreme Court implicates the biopharmaceutical competition.
